InvestorsHub Logo
Followers 826
Posts 119567
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 5046

Thursday, 10/20/2022 7:38:52 PM

Thursday, October 20, 2022 7:38:52 PM

Post# of 6091
Re: COVID-vaccine pricing in the commercial market

Starting in 1Q23—or whenever supplies under existing contracts government run out—PFE will begin selling its COVID vaccine in the US commercial market with a list price of $110-130 per single-use vial, which is about 4x the price per dose PFE realized from doses sold to the US and EU under government contracts. There will be some rebating/discounting of the commercial list price but this is nevertheless a big commercial opportunity, even with greatly reduced volume compared to the early days of the pandemic.

The list price for ex-US commercial sales has yet to be determined.

Source: Today’s PFE CC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News